drugset
drugset / Trial / NCT02908295

Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss: A Randomized Placebo-controlled Study

NCT02908295 ↗

Phase 4 Completed 20 enrolled Department of Medical Services Ministry of Public Health of Thailand
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparison of efficacy of rectal misoprostol for reduction amount of blood loss in women undergoing myomectomy, both open and laparoscopic approach

Timeline

Start
2016-09-01
Primary completion
2017-12-31
Completion
2018-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Rectal

Indications

No indication recorded.